Autoimmunity, Inflammation
1 clinical trials · Condition
◉ Watch Autoimmunity, Inflammation
| Record | Firm | Date |
|---|---|---|
| Secukinumab Open Label Roll-over Extension Protocol (NCT04638647) | Novartis Pharmaceuticals | 2020-12-22 |
Track Autoimmunity, Inflammation automatically
Every clearance here is in the API, with alerts when new ones post.